Braskem BAK
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 72nd percentile, 5-year average -1.6x
Below its usual level · 39th percentile, 5-year average -17.4x
Near the bottom of its 5-year range · 1st percentile, 5-year average 0.2x
#108 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | -0.20 | – | -17.38 | 39% (cheaper than usual) | – |
| PE | -0.46 | -2.65 | -1.65 | 72% (pricier than usual) | – |
| PS | 0.04 | 0.03 | 0.19 | 1% (cheaper than usual) | #108 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on BAK.
Sign in to join the discussion.